Antitumor effects of a polypeptide isolated from Tegillarca granosa linnaeus and the related molecular mechanism

Pakistan Journal of Pharmaceutical Sciences

Volumn 27, Issue 3, 2014, Pages 565-570

  Xu, Wenhua ^a   Chang, Zhishang ^a   Liu, Xiaoyan ^b   Jiang, Changqing ^c   Wang, Chunbo ^a   Xu, Luo ^a  

^a QINGDAO UNIVERSITY   (China)

^b Garrison Command Hospital of Qingdao   (China)

^c QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

Antitumor effects; Caspase 3; Ki67; Renal carcinoma OS RC 2 cells; The protein polypeptide

Indexed keywords

ACRIDINE ORANGE; ANTINEOPLASTIC AGENT; CASPASE 3; ETHIDIUM BROMIDE; KI 67 ANTIGEN; MESSENGER RNA; POLYPEPTIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CLAM; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; RENAL CARCINOMA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TEGILLARCA GRANOSA LINNAEUS; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARCIDAE; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; HUMANS; KI-67 ANTIGEN; KIDNEY NEOPLASMS; PEPTIDES;

EID: 84901414351     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Brodsky SV, Mendelev N, Melamed M and Ramaswamy G (2007). Vascular density and VEGF expression in hepatic lesions. J. Gastrointestion. Liver Dis., 16: 373-377.
2. Campbell SC, Novick AC and Bukowski RM (2007). Renal tumors (M). In: Campell's Urology, Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (editors), Saunders, Philadelphia, pp.1651-1725.
3. Chen B, Jiang L, Zhao W, Yu R and Hou XM (1997). Ameliorating effect of erythromycin on bleomycin-induced pulmonary fibrosis: Role of alveolar macrophage activation and cytokine release. Respirology, 2: 131-155.
4. Dvorak HF, Nagy JA, Feng D, Brown LF and Dvorak AM (1999). Vascular permeability factor vascular endothelial growth factor and the significance of microvascular hypcrpcnneability inangiogenesis. Curr. Top. Mivrobiol. Imunoi., 237: 97-132. (Pubitemid 28554861)
5. Galvan V, Chen S, Lu D, Logvinova A, Goldsmith P, Koo EH and Bredesen DE (2002). Caspase cleavage of members of the amyloid precursor family of proteins. J. Neurochem., 82: 283-294. (Pubitemid 34774619)
6. Gao MQ, Han YT, Zhu L, Chen SG, Hong ZY and Wang CB (2009). Cytotoxicity of natural extract from Tegillarca granosa on ovarian cancer cells is mediated by multiple molecules. Clin. Invest. Med., 32: 368-375.
7. Hainaut P and Hollstein M (2000). P53 and human cancer: The fast ten thousand mutations. Adv. Cancer. Res., 77: 81-137. (Pubitemid 29439303)
8. Herrmann E, Bierer S and Wülfing C (2010). Update on systemic therapies of metastatic renal cell carcinoma. World. J. Urol., 28: 303-309.
9. Jemal A, Siegel R, Xu J and Ward E (2010). Cancer statistics. CA. Cancer. J. Clin., 60: 277-300.
10. Kirchner H, Strumberg D, Bahl A and Overkamp F (2010). Patient-based strategy for systemic treatment of metastatic renal cell carcinoma. Expert. Rev. Anticancer. Thera., 10: 585-596.
11. Krause FS, Feil G and Bichler KH (2000). Immunohistochemical examinations (Ki67, p53. nm23) and DNA cytophotometry in bladder cancer. Anticancer. Res., 20: 5023-5028. (Pubitemid 32319073)
12. Li GY, Liu JZ, Yu XM, Chen SF, Zhang B, Zhang WF and Wang LX (2008). Effect of a seashell protein Haishengsu on cell growth and expression of apoptosis genes in leukemia K562 cells. Clin. Invest. Med., 31: 218-221.
13. Li GY, Liu JZ, Zhang B, Yang M, Chen SG, Hou M and Wang LX (2013). Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice. Adv. Med. Sci., 58: 112-117.
14. Li GY, Liu JZ, Chen SG, Zhang B, Wang CB and Wang LX (2010). Tegillarca granosa extract Haishengsu inhibits the expression of P-glycoprotein and induces apoptosis in drug-resistant K562/ADM cells. Pharm. Biol., 48: 529-533.
15. Liu ZX, Zhan SM, Yao RY, Fang LH, Yang X and Wang CB (2004). An experimental study on antitumor effect of Haishengsu injection. Chin. J. Mar. Drugs, 23: 35-37.
16. Liu JZ, Yang M, Li DP, Zhang B, Chen SG, Wang CB, Li GY and Wang LX (2009). Effect of Haishengsu on transplanted K562 and drug-resistant K562/ADM tumors: an experimental study. Clin. Invest. Med., 32: 117-123.
17. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell., 94: 481-490. (Pubitemid 28391864)
18. Malmström PU, Ren ZP, Sherif A, de la Torre M, Wester K and Thörn M (2002). Early metastatic progression of bladder carcinoma: Molecular profile of primary tumor and sentinel lymph node. J. Urol., 168: 2240-2244.
19. Mangues R, Symmans WF, Lu S, Schwartz S and Pellicer A (1996). Activated N-ras oncogene and N- ras proto-oncogene act through the same pathway for in vivo tumorigenesis. Oncogene., 13: 1053-1063. (Pubitemid 26329092)
20. Martin DA, Siegel RM, Zheng L and Lenardo MJ (1998). Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHal) death Signal. J. Biol. Chem., 274: 4345-4349. (Pubitemid 28103169)
21. Michor F, Iwasa Y and Nowak MA (2004). Dynamics of cancer progression. Nat. Rev. Cancer., 4: 197-205. (Pubitemid 38337499)
22. Prochownik EV (2008). c-Myc: linking transformation and genomic instability. Curt. Mol. Med., 8: 446-458.
23. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A (2000). Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes. Dev., 14: 31-44.
24. Shaw RJ and Cantley LC (2006). Ras, PI (3)K and mTOR signaling controls tumor cell growth. Nature, 441: 424-430. (Pubitemid 44050136)
25. Xu W, Jiang C, Kong X, Liang Y, Rong M and Liu W (2012). Chitooligosaccharides and N-acetyl-D-glucosamine stimulate peripheral blood mononuclear cell-mediated. Antitumor immune responses. Mol. Med. Report, 6: 385-390.
26. Yao RY, Chu X, Zhang YJ, Yang X, Liu XR and Wang CB (2005). Antitumor effect of Haishengsu extracted from Tegillarca granosa in vitro and in vivo. Chin. J. Mar. Drugs. 24: 33-36.